Report Cover

Global Preventable Vaccines Market Growth 2021-2026


According to this latest study, the 2020 growth of Preventable Vaccines will have significant change from previous year. By the most conservative estimates of global Preventable Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Preventable Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Preventable Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
    Adult Preventable Vaccines
    Pediatric Preventable Vaccines

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
    Bacterial Diseases
    Virus Diseases

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
    GlaxoSmithKline
    Merck
    Novartis
    Pfizer
    Sanofi
    Takeda Pharmaceutical
    Abbott
    Roche
    AstraZeneca
    Mitsubishi Tanabe Pharma
    Lupin
    Serum Institute of India
    LG Life Sciences
    S K Chemicals
    Shenzhen Kangtai Biological Products
    Sinovac Biotech
    Janssen Pharmaceuticals
    Crucell
    Bavarian Nordic
    Baxter
    Bharat Biotech
    Dynavax
    Bausch Health
    Protein Sciences
    Panacea Biotec
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Preventable Vaccines Consumption 2016-2026
        2.1.2 Preventable Vaccines Consumption CAGR by Region
    2.2 Preventable Vaccines Segment by Type
        2.2.1 Adult Preventable Vaccines
        2.2.2 Pediatric Preventable Vaccines
    2.3 Preventable Vaccines Sales by Type
        2.3.1 Global Preventable Vaccines Sales Market Share by Type (2016-2021)
        2.3.2 Global Preventable Vaccines Revenue and Market Share by Type (2016-2021)
        2.3.3 Global Preventable Vaccines Sale Price by Type (2016-2021)
    2.4 Preventable Vaccines Segment by Application
        2.4.1 Bacterial Diseases
        2.4.2 Virus Diseases
    2.5 Preventable Vaccines Sales by Application
        2.5.1 Global Preventable Vaccines Sale Market Share by Application (2016-2021)
        2.5.2 Global Preventable Vaccines Revenue and Market Share by Application (2016-2021)
        2.5.3 Global Preventable Vaccines Sale Price by Application (2016-2021)

3 Global Preventable Vaccines by Company
    3.1 Global Preventable Vaccines Sales Market Share by Company
        3.1.1 Global Preventable Vaccines Sales by Company (2019-2021)
        3.1.2 Global Preventable Vaccines Sales Market Share by Company (2019-2021)
    3.2 Global Preventable Vaccines Revenue Market Share by Company
        3.2.1 Global Preventable Vaccines Revenue by Company (2019-2021)
        3.2.2 Global Preventable Vaccines Revenue Market Share by Company (2019-2021)
    3.3 Global Preventable Vaccines Sale Price by Company
    3.4 Global Manufacturers Preventable Vaccines Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Preventable Vaccines Product Location Distribution
        3.4.2 Players Preventable Vaccines Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion

4 Preventable Vaccines by Region
    4.1 Global Preventable Vaccines by Region
        4.1.1 Global Preventable Vaccines Sales by Region
        4.1.2 Global Preventable Vaccines Revenue by Region
    4.2 Americas Preventable Vaccines Sales Growth
    4.3 APAC Preventable Vaccines Sales Growth
    4.4 Europe Preventable Vaccines Sales Growth
    4.5 Middle East & Africa Preventable Vaccines Sales Growth

5 Americas
    5.1 Americas Preventable Vaccines Sales by Country
        5.1.1 Americas Preventable Vaccines Sales by Country (2016-2021)
        5.1.2 Americas Preventable Vaccines Revenue by Country (2016-2021)
    5.2 Americas Preventable Vaccines Sales by Type
    5.3 Americas Preventable Vaccines Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Preventable Vaccines Sales by Region
        6.1.1 APAC Preventable Vaccines Sales by Region (2016-2021)
        6.1.2 APAC Preventable Vaccines Revenue by Region (2016-2021)
    6.2 APAC Preventable Vaccines Sales by Type
    6.3 APAC Preventable Vaccines Sales by Application
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Preventable Vaccines by Country
        7.1.1 Europe Preventable Vaccines Sales by Country (2016-2021)
        7.1.2 Europe Preventable Vaccines Revenue by Country (2016-2021)
    7.2 Europe Preventable Vaccines Sales by Type
    7.3 Europe Preventable Vaccines Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Preventable Vaccines by Country
        8.1.1 Middle East & Africa Preventable Vaccines Sales by Country (2016-2021)
        8.1.2 Middle East & Africa Preventable Vaccines Revenue by Country (2016-2021)
    8.2 Middle East & Africa Preventable Vaccines Sales by Type
    8.3 Middle East & Africa Preventable Vaccines Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Country

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Marketing, Distributors and Customer
    10.1 Sales Channel
        10.1.1 Direct Channels
        10.1.2 Indirect Channels
    10.2 Preventable Vaccines Distributors
    10.3 Preventable Vaccines Customer

11 Global Preventable Vaccines Market Forecast
    11.1 Global Preventable Vaccines Forecast by Region
        11.1.1 Global Preventable Vaccines Forecast by Regions (2021-2026)
        11.2.2 Global Preventable Vaccines Revenue Forecast by Regions (2021-2026)
    11.2 Americas Forecast by Countries
    11.3 APAC Forecast by Region
    11.4 Europe Forecast by Countries
    11.5 Middle East & Africa Forecast by Countries
    11.6 Global Preventable Vaccines Forecast by Type
    11.7 Global Preventable Vaccines Forecast by Application

12 Key Players Analysis
    12.1 GlaxoSmithKline
        12.1.1 GlaxoSmithKline GlaxoSmithKline Company Information
        12.1.2 GlaxoSmithKline Preventable Vaccines Product Offered
        12.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.1.4 GlaxoSmithKline Main Business Overview
        12.1.5 GlaxoSmithKline Latest Developments
    12.2 Merck
        12.2.1 Merck Company Information
        12.2.2 Merck Preventable Vaccines Product Offered
        12.2.3 Merck Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.2.4 Merck Main Business Overview
        12.2.5 Merck Latest Developments
    12.3 Novartis
        12.3.1 Novartis Company Information
        12.3.2 Novartis Preventable Vaccines Product Offered
        12.3.3 Novartis Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.3.4 Novartis Main Business Overview
        12.3.5 Novartis Latest Developments
    12.4 Pfizer
        12.4.1 Pfizer Company Information
        12.4.2 Pfizer Preventable Vaccines Product Offered
        12.4.3 Pfizer Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.4.4 Pfizer Main Business Overview
        12.4.5 Pfizer Latest Developments
    12.5 Sanofi
        12.5.1 Sanofi Company Information
        12.5.2 Sanofi Preventable Vaccines Product Offered
        12.5.3 Sanofi Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.5.4 Sanofi Main Business Overview
        12.5.5 Sanofi Latest Developments
    12.6 Takeda Pharmaceutical
        12.6.1 Takeda Pharmaceutical Company Information
        12.6.2 Takeda Pharmaceutical Preventable Vaccines Product Offered
        12.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.6.4 Takeda Pharmaceutical Main Business Overview
        12.6.5 Takeda Pharmaceutical Latest Developments
    12.7 Abbott
        12.7.1 Abbott Company Information
        12.7.2 Abbott Preventable Vaccines Product Offered
        12.7.3 Abbott Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.7.4 Abbott Main Business Overview
        12.7.5 Abbott Latest Developments
    12.8 Roche
        12.8.1 Roche Company Information
        12.8.2 Roche Preventable Vaccines Product Offered
        12.8.3 Roche Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.8.4 Roche Main Business Overview
        12.8.5 Roche Latest Developments
    12.9 AstraZeneca
        12.9.1 AstraZeneca Company Information
        12.9.2 AstraZeneca Preventable Vaccines Product Offered
        12.9.3 AstraZeneca Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.9.4 AstraZeneca Main Business Overview
        12.9.5 AstraZeneca Latest Developments
    12.10 Mitsubishi Tanabe Pharma
        12.10.1 Mitsubishi Tanabe Pharma Company Information
        12.10.2 Mitsubishi Tanabe Pharma Preventable Vaccines Product Offered
        12.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.10.4 Mitsubishi Tanabe Pharma Main Business Overview
        12.10.5 Mitsubishi Tanabe Pharma Latest Developments
    12.11 Lupin
        12.11.1 Lupin Company Information
        12.11.2 Lupin Preventable Vaccines Product Offered
        12.11.3 Lupin Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.11.4 Lupin Main Business Overview
        12.11.5 Lupin Latest Developments
    12.12 Serum Institute of India
        12.12.1 Serum Institute of India Company Information
        12.12.2 Serum Institute of India Preventable Vaccines Product Offered
        12.12.3 Serum Institute of India Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.12.4 Serum Institute of India Main Business Overview
        12.12.5 Serum Institute of India Latest Developments
    12.13 LG Life Sciences
        12.13.1 LG Life Sciences Company Information
        12.13.2 LG Life Sciences Preventable Vaccines Product Offered
        12.13.3 LG Life Sciences Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.13.4 LG Life Sciences Main Business Overview
        12.13.5 LG Life Sciences Latest Developments
    12.14 S K Chemicals
        12.14.1 S K Chemicals Company Information
        12.14.2 S K Chemicals Preventable Vaccines Product Offered
        12.14.3 S K Chemicals Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.14.4 S K Chemicals Main Business Overview
        12.14.5 S K Chemicals Latest Developments
    12.15 Shenzhen Kangtai Biological Products
        12.15.1 Shenzhen Kangtai Biological Products Company Information
        12.15.2 Shenzhen Kangtai Biological Products Preventable Vaccines Product Offered
        12.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.15.4 Shenzhen Kangtai Biological Products Main Business Overview
        12.15.5 Shenzhen Kangtai Biological Products Latest Developments
    12.16 Sinovac Biotech
        12.16.1 Sinovac Biotech Company Information
        12.16.2 Sinovac Biotech Preventable Vaccines Product Offered
        12.16.3 Sinovac Biotech Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.16.4 Sinovac Biotech Main Business Overview
        12.16.5 Sinovac Biotech Latest Developments
    12.17 Janssen Pharmaceuticals
        12.17.1 Janssen Pharmaceuticals Company Information
        12.17.2 Janssen Pharmaceuticals Preventable Vaccines Product Offered
        12.17.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.17.4 Janssen Pharmaceuticals Main Business Overview
        12.17.5 Janssen Pharmaceuticals Latest Developments
    12.18 Crucell
        12.18.1 Crucell Company Information
        12.18.2 Crucell Preventable Vaccines Product Offered
        12.18.3 Crucell Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.18.4 Crucell Main Business Overview
        12.18.5 Crucell Latest Developments
    12.19 Bavarian Nordic
        12.19.1 Bavarian Nordic Company Information
        12.19.2 Bavarian Nordic Preventable Vaccines Product Offered
        12.19.3 Bavarian Nordic Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.19.4 Bavarian Nordic Main Business Overview
        12.19.5 Bavarian Nordic Latest Developments
    12.20 Baxter
        12.20.1 Baxter Company Information
        12.20.2 Baxter Preventable Vaccines Product Offered
        12.20.3 Baxter Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.20.4 Baxter Main Business Overview
        12.20.5 Baxter Latest Developments
    12.21 Bharat Biotech
        12.21.1 Bharat Biotech Company Information
        12.21.2 Bharat Biotech Preventable Vaccines Product Offered
        12.21.3 Bharat Biotech Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.21.4 Bharat Biotech Main Business Overview
        12.21.5 Bharat Biotech Latest Developments
    12.22 Dynavax
        12.22.1 Dynavax Company Information
        12.22.2 Dynavax Preventable Vaccines Product Offered
        12.22.3 Dynavax Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.22.4 Dynavax Main Business Overview
        12.22.5 Dynavax Latest Developments
    12.23 Bausch Health
        12.23.1 Bausch Health Company Information
        12.23.2 Bausch Health Preventable Vaccines Product Offered
        12.23.3 Bausch Health Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.23.4 Bausch Health Main Business Overview
        12.23.5 Bausch Health Latest Developments
    12.24 Protein Sciences
        12.24.1 Protein Sciences Company Information
        12.24.2 Protein Sciences Preventable Vaccines Product Offered
        12.24.3 Protein Sciences Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.24.4 Protein Sciences Main Business Overview
        12.24.5 Protein Sciences Latest Developments
    12.25 Panacea Biotec
        12.25.1 Panacea Biotec Company Information
        12.25.2 Panacea Biotec Preventable Vaccines Product Offered
        12.25.3 Panacea Biotec Preventable Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
        12.25.4 Panacea Biotec Main Business Overview
        12.25.5 Panacea Biotec Latest Developments

13 Research Findings and Conclusion

List of Tables Table 1. Preventable Vaccines Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Adult Preventable Vaccines Table 3. Major Players of Pediatric Preventable Vaccines Table 4. Global Preventable Vaccines Sales by Type (2016-2021) & (K Units) Table 5. Global Preventable Vaccines Sales Market Share by Type (2016-2021) Table 6. Global Preventable Vaccines Revenue by Type (2016-2021) & ($ million) Table 7. Global Preventable Vaccines Revenue Market Share by Type (2016-2021) Table 8. Global Preventable Vaccines Sale Price by Type (2016-2021) Table 9. Global Preventable Vaccines Sales by Application (2016-2021) & (K Units) Table 10. Global Preventable Vaccines Sales Market Share by Application (2016-2021) Table 11. Global Preventable Vaccines Value by Application (2016-2021) Table 12. Global Preventable Vaccines Revenue Market Share by Application (2016-2021) Table 13. Global Preventable Vaccines Sale Price by Application (2016-2021) Table 14. Global Preventable Vaccines Sales by Company (2019-2021) & (K Units) Table 15. Global Preventable Vaccines Sales Market Share by Company (2019-2021) Table 16. Global Preventable Vaccines Revenue by Company (2019-2021) ($ Millions) Table 17. Global Preventable Vaccines Revenue Market Share by Company (2019-2021) Table 18. Global Preventable Vaccines Sale Price by Company (2019-2021) Table 19. Key Manufacturers Preventable Vaccines Producing Area Distribution and Sales Area Table 20. Players Preventable Vaccines Products Offered Table 21. Preventable Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Preventable Vaccines Sales by Region (2016-2021) (K Units) Table 25. Global Preventable Vaccines Sales Market Share by Region (2016-2021) Table 26. Global Preventable Vaccines Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Preventable Vaccines Revenue Market Share by Region (2016-2021) Table 28. Americas Preventable Vaccines Sales by Country (2016-2021) & (K Units) Table 29. Americas Preventable Vaccines Sales Market Share by Country (2016-2021) Table 30. Americas Preventable Vaccines Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Preventable Vaccines Revenue Market Share by Country (2016-2021) Table 32. Americas Preventable Vaccines Sales by Type (2016-2021) & (K Units) Table 33. Americas Preventable Vaccines Sales Market Share by Type (2016-2021) Table 34. Americas Preventable Vaccines Sales by Application (2016-2021) & (K Units) Table 35. Americas Preventable Vaccines Sales Market Share by Application (2016-2021) Table 36. APAC Preventable Vaccines Sales by Region (2016-2021) & (K Units) Table 37. APAC Preventable Vaccines Sales Market Share by Region (2016-2021) Table 38. APAC Preventable Vaccines Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Preventable Vaccines Revenue Market Share by Region (2016-2021) Table 40. APAC Preventable Vaccines Sales by Type (2016-2021) & (K Units) Table 41. APAC Preventable Vaccines Sales Market Share by Type (2016-2021) Table 42. APAC Preventable Vaccines Sales by Application (2016-2021) & (K Units) Table 43. APAC Preventable Vaccines Sales Market Share by Application (2016-2021) Table 44. Europe Preventable Vaccines Sales by Country (2016-2021) & (K Units) Table 45. Europe Preventable Vaccines Sales Market Share by Country (2016-2021) Table 46. Europe Preventable Vaccines Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Preventable Vaccines Revenue Market Share by Country (2016-2021) Table 48. Europe Preventable Vaccines Sales by Type (2016-2021) & (K Units) Table 49. Europe Preventable Vaccines Sales Market Share by Type (2016-2021) Table 50. Europe Preventable Vaccines Sales by Application (2016-2021) & (K Units) Table 51. Europe Preventable Vaccines Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Preventable Vaccines Sales by Country (2016-2021) & (K Units) Table 53. Middle East & Africa Preventable Vaccines Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Preventable Vaccines Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Preventable Vaccines Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Preventable Vaccines Sales by Type (2016-2021) & (K Units) Table 57. Middle East & Africa Preventable Vaccines Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Preventable Vaccines Sales by Application (2016-2021) & (K Units) Table 59. Middle East & Africa Preventable Vaccines Sales Market Share by Application (2016-2021) Table 60. Global Preventable Vaccines Sales Forecast by Type (2021-2026) & (K Units) Table 61. Global Preventable Vaccines Sales Market Share Forecast by Type (2021-2026) Table 62. Global Preventable Vaccines Revenue Forecast by Type (2021-2026) & ($ Millions) Table 63. Global Preventable Vaccines Revenue Market Share Forecast by Type (2021-2026) Table 64. Global Preventable Vaccines Sales Forecast by Application (2021-2026) & (K Units) Table 65. Global Preventable Vaccines Sales Market Share Forecast by Application (2021-2026) Table 66. Global Preventable Vaccines Revenue Forecast by Application (2021-2026) & ($ Millions) Table 67. Global Preventable Vaccines Revenue Market Share Forecast by Application (2021-2026) Table 68. GlaxoSmithKline Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 69. GlaxoSmithKline Preventable Vaccines Product Offered Table 70. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 71. GlaxoSmithKline Main Business Table 72. GlaxoSmithKline Latest Developments Table 73. Merck Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 74. Merck Preventable Vaccines Product Offered Table 75. Merck Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 76. Merck Main Business Table 77. Merck Latest Developments Table 78. Novartis Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 79. Novartis Preventable Vaccines Product Offered Table 80. Novartis Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 81. Novartis Main Business Table 82. Novartis Latest Developments Table 83. Pfizer Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 84. Pfizer Preventable Vaccines Product Offered Table 85. Pfizer Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 86. Pfizer Main Business Table 87. Pfizer Latest Developments Table 88. Sanofi Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 89. Sanofi Preventable Vaccines Product Offered Table 90. Sanofi Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 91. Sanofi Main Business Table 92. Sanofi Latest Developments Table 93. Takeda Pharmaceutical Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 94. Takeda Pharmaceutical Preventable Vaccines Product Offered Table 95. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 96. Takeda Pharmaceutical Main Business Table 97. Takeda Pharmaceutical Latest Developments Table 98. Abbott Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 99. Abbott Preventable Vaccines Product Offered Table 100. Abbott Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 101. Abbott Main Business Table 102. Abbott Latest Developments Table 103. Roche Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 104. Roche Preventable Vaccines Product Offered Table 105. Roche Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 106. Roche Main Business Table 107. Roche Latest Developments Table 108. AstraZeneca Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 109. AstraZeneca Preventable Vaccines Product Offered Table 110. AstraZeneca Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 111. AstraZeneca Main Business Table 112. AstraZeneca Latest Developments Table 113. Mitsubishi Tanabe Pharma Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 114. Mitsubishi Tanabe Pharma Preventable Vaccines Product Offered Table 115. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 116. Mitsubishi Tanabe Pharma Main Business Table 117. Mitsubishi Tanabe Pharma Latest Developments Table 118. Lupin Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 119. Lupin Preventable Vaccines Product Offered Table 120. Lupin Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 121. Lupin Main Business Table 122. Lupin Latest Developments Table 123. Serum Institute of India Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 124. Serum Institute of India Preventable Vaccines Product Offered Table 125. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 126. Serum Institute of India Main Business Table 127. Serum Institute of India Latest Developments Table 128. LG Life Sciences Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 129. LG Life Sciences Preventable Vaccines Product Offered Table 130. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 131. LG Life Sciences Main Business Table 132. LG Life Sciences Latest Developments Table 133. S K Chemicals Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 134. S K Chemicals Preventable Vaccines Product Offered Table 135. S K Chemicals Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 136. S K Chemicals Main Business Table 137. S K Chemicals Latest Developments Table 138. Shenzhen Kangtai Biological Products Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 139. Shenzhen Kangtai Biological Products Preventable Vaccines Product Offered Table 140. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 141. Shenzhen Kangtai Biological Products Main Business Table 142. Shenzhen Kangtai Biological Products Latest Developments Table 143. Sinovac Biotech Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 144. Sinovac Biotech Preventable Vaccines Product Offered Table 145. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 146. Sinovac Biotech Main Business Table 147. Sinovac Biotech Latest Developments Table 148. Janssen Pharmaceuticals Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 149. Janssen Pharmaceuticals Preventable Vaccines Product Offered Table 150. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 151. Janssen Pharmaceuticals Main Business Table 152. Janssen Pharmaceuticals Latest Developments Table 153. Crucell Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 154. Crucell Preventable Vaccines Product Offered Table 155. Crucell Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 156. Crucell Main Business Table 157. Crucell Latest Developments Table 158. Bavarian Nordic Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 159. Bavarian Nordic Preventable Vaccines Product Offered Table 160. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 161. Bavarian Nordic Main Business Table 162. Bavarian Nordic Latest Developments Table 163. Baxter Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 164. Baxter Preventable Vaccines Product Offered Table 165. Baxter Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 166. Baxter Main Business Table 167. Baxter Latest Developments Table 168. Bharat Biotech Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 169. Bharat Biotech Preventable Vaccines Product Offered Table 170. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 171. Bharat Biotech Main Business Table 172. Bharat Biotech Latest Developments Table 173. Dynavax Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 174. Dynavax Preventable Vaccines Product Offered Table 175. Dynavax Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 176. Dynavax Main Business Table 177. Dynavax Latest Developments Table 178. Bausch Health Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 179. Bausch Health Preventable Vaccines Product Offered Table 180. Bausch Health Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 181. Bausch Health Main Business Table 182. Bausch Health Latest Developments Table 183. Protein Sciences Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 184. Protein Sciences Preventable Vaccines Product Offered Table 185. Protein Sciences Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 186. Protein Sciences Main Business Table 187. Protein Sciences Latest Developments Table 188. Panacea Biotec Basic Information, Preventable Vaccines Manufacturing Base, Sales Area and Its Competitors Table 189. Panacea Biotec Preventable Vaccines Product Offered Table 190. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 191. Panacea Biotec Main Business Table 192. Panacea Biotec Latest Developments List of Figures Figure 1. Picture of Preventable Vaccines Figure 2. Preventable Vaccines Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Preventable Vaccines Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Preventable Vaccines Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Preventable Vaccines Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Adult Preventable Vaccines Figure 10. Product Picture of Pediatric Preventable Vaccines Figure 11. Global Preventable Vaccines Sales Market Share by Type in 2020 Figure 12. Global Preventable Vaccines Revenue Market Share by Type (2016-2021) Figure 13. Preventable Vaccines Consumed in Bacterial Diseases Figure 14. Global Preventable Vaccines Market: Bacterial Diseases (2016-2021) & (K Units) Figure 15. Preventable Vaccines Consumed in Virus Diseases Figure 16. Global Preventable Vaccines Market: Virus Diseases (2016-2021) & (K Units) Figure 17. Global Preventable Vaccines Sales Market Share by Application (2016-2021) Figure 18. Global Preventable Vaccines Revenue Market Share by Application in 2020 Figure 19. Global Preventable Vaccines Revenue Market by Company in 2020 ($ Million) Figure 20. Global Preventable Vaccines Revenue Market Share by Company in 2020 Figure 21. Global Preventable Vaccines Sales Market Share by Regions (2016-2021) Figure 22. Global Preventable Vaccines Revenue Market Share by Region in 2020 Figure 23. Americas Preventable Vaccines Sales 2016-2021 (K Units) Figure 24. Americas Preventable Vaccines Revenue 2016-2021 ($ Millions) Figure 25. APAC Preventable Vaccines Sales 2016-2021 (K Units) Figure 26. APAC Preventable Vaccines Revenue 2016-2021 ($ Millions) Figure 27. Europe Preventable Vaccines Sales 2016-2021 (K Units) Figure 28. Europe Preventable Vaccines Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Preventable Vaccines Sales 2016-2021 (K Units) Figure 30. Middle East & Africa Preventable Vaccines Revenue 2016-2021 ($ Millions) Figure 31. Americas Preventable Vaccines Sales Market Share by Country in 2020 Figure 32. Americas Preventable Vaccines Revenue Market Share by Country in 2020 Figure 33. Americas Preventable Vaccines Sales Market Share by Type in 2020 Figure 34. Americas Preventable Vaccines Sales Market Share by Application in 2020 Figure 35. United States Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Preventable Vaccines Sales Market Share by Region in 2020 Figure 40. APAC Preventable Vaccines Revenue Market Share by Regions in 2020 Figure 41. APAC Preventable Vaccines Sales Market Share by Type in 2020 Figure 42. APAC Preventable Vaccines Sales Market Share by Application in 2020 Figure 43. China Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 47. India Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Preventable Vaccines Sales Market Share by Country in 2020 Figure 50. Europe Preventable Vaccines Revenue Market Share by Country in 2020 Figure 51. Europe Preventable Vaccines Sales Market Share by Type in 2020 Figure 52. Europe Preventable Vaccines Sales Market Share by Application in 2020 Figure 53. Germany Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 54. France Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Preventable Vaccines Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Preventable Vaccines Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Preventable Vaccines Sales Market Share by Type in 2020 Figure 61. Middle East & Africa Preventable Vaccines Sales Market Share by Application in 2020 Figure 62. Egypt Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Preventable Vaccines Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: LP Information Inc
Chat with us